<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03861988</url>
  </required_header>
  <id_info>
    <org_study_id>49114</org_study_id>
    <nct_id>NCT03861988</nct_id>
  </id_info>
  <brief_title>Intraoperative Ketamine Versus Saline in Depressed Patients Undergoing Anesthesia for Non-cardiac Surgery</brief_title>
  <official_title>Double-blind Trial of Intraoperative Ketamine Versus Saline in Depressed Patients Undergoing Anesthesia for Non-cardiac Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Stanford University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Stanford University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluates whether ketamine, given as part of an anesthetic, improves depression&#xD;
      symptoms in depressed patients undergoing total joint replacement surgery. Half of&#xD;
      participants will receive a ketamine infusion during surgery, while the other half will&#xD;
      receive a placebo (normal saline) during surgery.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Major Depressive Disorder (MDD) is widely prevalent among patients preparing to have surgery,&#xD;
      and is a known risk factor for complications after surgery, including wound infection,&#xD;
      myocardial infarction and opioid use disorder. Ketamine has emerged as an effective,&#xD;
      rapid-acting antidepressant therapy for patients with MDD, and may be a useful tool to&#xD;
      prevent MDD-related morbidity in the perioperative period. Ketamine has been well studied for&#xD;
      MDD in outpatient clinics where it is given as an infusion (0.5 mg/kg over 40 minutes) in&#xD;
      awake patients. Ketamine is often used as part of an anesthetic cocktail in sedated or&#xD;
      anesthetized patients, but it is unknown whether ketamine has an antidepressant effect in&#xD;
      this context. The investigators will determine whether a ketamine infusion, compared to&#xD;
      placebo (normal saline infusion), has an antidepressant effect when given during surgical&#xD;
      anesthesia. If ketamine is an effective antidepressant in this population under anesthesia,&#xD;
      its use could be incorporated into a set of interventions to minimize the perioperative&#xD;
      complications associated with MDD.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 22, 2019</start_date>
  <completion_date type="Anticipated">January 2022</completion_date>
  <primary_completion_date type="Anticipated">December 2021</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
    <masking_description>Masking is for double blind phase only.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Composite score on Hospital Anxiety and Depression Scale (HADS) and Montgomery-Asberg Depression Rating Scales (MADRS)</measure>
    <time_frame>1 to 5 days post procedure (up to 20 minutes to complete survey)</time_frame>
    <description>This outcome measures a composite of the HADS and MADRS depression rating scales. The composite score range is 0 to 81. A lower score indicate lower severity of symptoms. The assessment for this outcome measure will be taken once between days 1 and 5 post procedure.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain at surgical site: scale of 0-10</measure>
    <time_frame>1 to 5 days post procedure (up to 5 minutes to complete survey)</time_frame>
    <description>This outcome measures average pain at the surgical site as reported by the patient on a scale of 0-10, with lower scores corresponding to less pain (&quot;0&quot; = no pain) and higher scores corresponding to more pain. The assessment for this outcome measure will be taken once between days 1 and 5 following the procedure.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain at surgical site: scale of 0-10</measure>
    <time_frame>14 days post procedure (up to 5 minutes to complete survey)</time_frame>
    <description>This outcome measures average pain at the surgical site as reported by the patient on a scale of 0-10, with lower scores corresponding to less pain (&quot;0&quot; = no pain) and higher scores corresponding to more pain.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Opioid consumption</measure>
    <time_frame>0 to 14 days post procedure</time_frame>
    <description>This outcome measures how many cumulative morphine-equivalents milligrams of opioid pain medication the patient has taken.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">45</enrollment>
  <condition>Major Depressive Disorder</condition>
  <condition>Surgery</condition>
  <condition>Orthopedic Disorder</condition>
  <arm_group>
    <arm_group_label>Open label ketamine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will receive an intravenous ketamine infusion during surgery.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Double blind ketamine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will receive an intravenous ketamine infusion during surgery.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Double blind placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Participants will receive placebo (normal saline infusion) during surgery.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ketamine</intervention_name>
    <description>0.5 mg/kg over 40 minutes, intravenous.</description>
    <arm_group_label>Double blind ketamine</arm_group_label>
    <arm_group_label>Open label ketamine</arm_group_label>
    <other_name>Ketalar.</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Normal saline (placebo)</intervention_name>
    <description>Normal saline infusion over 40 minutes, equivalent volume to ketamine infusion.</description>
    <arm_group_label>Double blind placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patient presenting for primary total joint arthroplasty&#xD;
&#xD;
          -  Major Depressive Disorder&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pregnant of breastfeeding women&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Boris D Heifets, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Stanford University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Stanford University</name>
      <address>
        <city>Stanford</city>
        <state>California</state>
        <zip>94305</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Boris D Heifets, MD, PhD</last_name>
      <phone>917-620-4241</phone>
      <email>bheifets@stanford.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>March 1, 2019</study_first_submitted>
  <study_first_submitted_qc>March 4, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">March 5, 2019</study_first_posted>
  <last_update_submitted>March 15, 2021</last_update_submitted>
  <last_update_submitted_qc>March 15, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 17, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Stanford University</investigator_affiliation>
    <investigator_full_name>Boris D. Heifets</investigator_full_name>
    <investigator_title>Assistant Professor of Anesthesiology</investigator_title>
  </responsible_party>
  <keyword>depression</keyword>
  <keyword>ketamine</keyword>
  <keyword>anesthesia</keyword>
  <keyword>total joint arthroplasty</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Musculoskeletal Diseases</mesh_term>
    <mesh_term>Disease</mesh_term>
    <mesh_term>Depressive Disorder</mesh_term>
    <mesh_term>Depressive Disorder, Major</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ketamine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>No current plan to share data.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

